The Indian market is expected to open flat on Tuesday tracking muted trend seen in other Asian markets.
Here is a list of top Ten stocks that are likely to be in focus today:
RIL: Reliance IndustriesBSE -0.94 %, along with Indian Institute of Petroleum (IIP) at Dehradun, has developed a technology which restricts benzene content in the gasoline pool to address the health and environmental concerns, the Mukesh Ambani-led company said on Monday.
Yes Bank Ltd: Y es Bank has hired Goldman Sachs Group Inc. to help the lender raise as much as $1 billion through a so-called qualified institutional placement (QIP) offer, according to two people aware of the development.
Mahanagar Gas IPO: Country’s second largest CNG retailer Mahanagar Gas has mopped up Rs 309 crore from anchor investors, a day ahead of its initial share sale.
Suzlon Energy: Hong Kong based CLP Group has forayed into the Indian solar energy market by acquiring 49% stake in Suzlon EnergyBSE 1.43 %’s 100 mw project in Telangana,
Eros International: Eros International Media said it will acquire 50 per cent stake in Puja Entertainment and Films but did not disclose the amount involved in the deal.
Reliance Communication: Merger talks between Reliance CommunicationsBSE 2.16 % (RCom) and Aircel will be extended by a couple of weeks, as both parties are thrashing out the final contours of the deal with their bankers, said a media report.
Apollo Hospitals: Apollo HospitalsBSE 1.13 % Group and Hainan Ecological Smart City Group (HESCG), a Chinese infrastructure company on Monday signed an MoU to jointly develop an integrated modern health care services facility and systems in Hainan province .
Tata Motors: United Kingdom’s likely exit from the European Union (EU) may affect adversely operations at Jaguar Land Rover (JLR), which contributes almost 90 per cent to profits of auto major Tata Motors.
Cadila Healthcare: ZydusBSE -0.86 % Healthcare, a subsidiary of Cadila HealthcareBSE 0.21 %, said it has acquired two abbreviated new drug applications (ANDAs) from Teva Pharmaceutical in the US for an undisclosed sum.
Nestle India: Nestle India is embarking on a product offensive, launching up to 25 products across various categories to fend off ‘disruptive competition’ from new rivals like Patanjali.